{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:13:09Z","timestamp":1790413989027,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T00:00:00Z","timestamp":1249344000000},"content-version":"vor","delay-in-days":5148,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1995,7]]},"abstract":"<jats:p><jats:bold>Abstract. <\/jats:bold> <jats:bold>Objectives.<\/jats:bold> The majority of post\u2010thrombotic women are barred from using oral contraceptives. We evaluated this policy for its clinical relevance.<\/jats:p><jats:p><jats:bold>Design.<\/jats:bold> A meta\u2010analysis of controlled studies between 1960 and 1993.<\/jats:p><jats:p><jats:bold>Setting.<\/jats:bold> A Medline computer search, from 1966 to 1993, in multiple languages, with the following index terms: thrombosis, thrombopheblitis, vein, venous, pulmonary embolism, contraceptives, oestrogen, oral.<\/jats:p><jats:p><jats:bold>Study selection.<\/jats:bold> A total of 588 articles or abstracts were reviewed for controlled studies, in which an index group was compared with a control group. Included were one randomized trial, six follow\u2010up studies and eight case\u2010control studies.<\/jats:p><jats:p><jats:bold>Main outcome measures.<\/jats:bold> Summary thrombosis risk for oral contraceptive users, number needed to discontinue oral contraceptives to prevent one (recurrent) thrombosis, comparison of additional unwanted pregnancies and postpartum thrombosis between alternative birth\u2010control methods.<\/jats:p><jats:p><jats:bold>Results.<\/jats:bold> The studies proved highly heterogeneous with regard to size and direction of the risk estimate. The summary relative risk of first thrombosis during oral contraceptive use was 2.9 (95% CI, 0.5\u201317). Since the risk of thrombosis recurrence is not well known, we estimated alternatives, making various hypothetical assumptions, wherein women would continue to take oral contraceptives after a first episode of thrombosis, or stop and switch to use of an intra\u2010uterine device, condom or the progestogen\u2010 only pill. Depending on the assumptions with regard to recurrence risk and the existence of possible subgroups with genetic coagulation defects, the cost\u2010 benefit ratio of advising against the use of oral contraceptives after a first thrombosis varied tremendously.<\/jats:p><jats:p><jats:bold>Conclusions.<\/jats:bold> Our analysis shows that we lack the necessary data for recurrence risk of venous thrombosis during continuing use of oral contraceptives, or after switching to other modes of contraception. This reflects the clinical uncertainties that result in highly contradictory advice to young women who have experienced a first thrombosis. Only follow\u2010up studies on recurrence risk will settle the issue.<\/jats:p>","DOI":"10.1111\/j.1365-2796.1995.tb00896.x","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T09:26:14Z","timestamp":1249377974000},"page":"31-37","source":"Crossref","is-referenced-by-count":31,"title":["Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties"],"prefix":"10.1111","volume":"238","author":[{"given":"T.","family":"KOSTER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.\u2010A.","family":"SMALL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. R.","family":"ROSENDAAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"HELMERHORST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)91061-3"},{"key":"e_1_2_1_3_2","first-page":"187","volume-title":"Clinical Epidemiology. A Basic Science for Clinical Medicine.","author":"Sackett DL","year":"1991"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)80081-9"},{"key":"e_1_2_1_5_2","first-page":"476","volume-title":"Statistical Yearbook 1993.","author":"Central Bureau of Statistics","year":"1993"},{"key":"e_1_2_1_6_2","first-page":"1185","volume-title":"Hemostasis and Thrombosis. Basic Principles and Clinical Practice.","author":"Carter C.","year":"1987"},{"key":"e_1_2_1_7_2","first-page":"558","article-title":"A guide to interpreting contraceptive efficacy studies","volume":"76","author":"Trussel J.","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036298"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6619.391"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5599.193"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.1.48"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490130077034"},{"key":"e_1_2_1_13_2","first-page":"267","article-title":"Oral contraception and thrombo\u2010embolic disease","volume":"13","author":"Royal College of Practitioners","year":"1967","journal-title":"J R Coll Gen Pract"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a121082"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5658.651"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(75)90517-7"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112646"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/oxfordjournals.aje.a112803","article-title":"Increased risk of thrombosis due to oral contraceptives; a further report","volume":"110","author":"Maguire MG","year":"1979","journal-title":"Am J Epidemiol"},{"key":"e_1_2_1_19_2","first-page":"91","article-title":"Venous thromboembolism in relation to oral contraceptive use","volume":"69","author":"Helmrich SP","year":"1987","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_20_2","first-page":"417","article-title":"Cardiovascular disease and use of oral contraceptives","volume":"67","author":"WHO Collaborative Study.","year":"1989","journal-title":"WHO Bulletin OMS"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1974.tb70899.x"},{"key":"e_1_2_1_22_2","first-page":"393","article-title":"Oral contraceptives. venous thrombosis and varicose veins","volume":"28","author":"Royal College of General Practitioners.","year":"1978","journal-title":"J R Coll Gen Pract"},{"key":"e_1_2_1_23_2","first-page":"22","article-title":"Oral contraceptive steroids and thrombophlebitis","volume":"71","author":"Diddle AW","year":"1978","journal-title":"J Tenn Med Assoc"},{"key":"e_1_2_1_24_2","first-page":"299","article-title":"Oral contraceptives and nonfatal vascular disease: recent experience","volume":"59","author":"Porter JB","year":"1982","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_25_2","first-page":"1","article-title":"Oral contraceptives and nonfatal vascular disease","volume":"66","author":"Porter JB","year":"1985","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6519.526"},{"key":"e_1_2_1_27_2","first-page":"259","article-title":"Thrombophlebitis among oral and nonoral contraceptive users","volume":"38","author":"Fuertes de la Haba A.","year":"1971","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90286-0"},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (APC\u2010resistance)","volume":"85","author":"Rosendaal FR","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_30_2","first-page":"147","article-title":"Oral contraceptive use and cardiovascular disease: is the relationship real or due to study bias?","volume":"35","author":"Katerndahl DA","year":"1992","journal-title":"J Fam Pract"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4159\/9780674040243","volume-title":"Summing Up: the Science of Reviewing Research.","author":"Light RS","year":"1984"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/19.4.931"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115799"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6883.956"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91550-0"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603273141305"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198902093200602"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-197805000-00009"},{"key":"e_1_2_1_39_2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0038-1642480","article-title":"Thrombotic risk of women with hereditary antithrombin III, protein C\u2010 and protein S deficiency taking oral contraceptive medication","volume":"71","author":"Pabinger I.","year":"1994","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/369064a0"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1645218"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.1995.tb00896.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.1995.tb00896.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T14:48:51Z","timestamp":1698331731000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.1995.tb00896.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,7]]}},"alternative-id":["10.1111\/j.1365-2796.1995.tb00896.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.1995.tb00896.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7]]}}}